Nabriva Therapeutics' lefamulin application accepted for review in China
November 29 2021 - 9:34AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Nabriva Therapeutics (NASDAQ:NBRV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nabriva Therapeutics (NASDAQ:NBRV)
Historical Stock Chart
From Sep 2023 to Sep 2024